Revvity to acquire human cell design in push to advance metabolic disease drug discovery
The deal is aimed at strengthening Revvity’s capabilities in diabetes, obesity and other metabolic disease research
The deal is aimed at strengthening Revvity’s capabilities in diabetes, obesity and other metabolic disease research
A key focus of the engagement was the regulatory framework governing microbial resources and the need to facilitate greater access to authenticated microbial type cultures for researchers and industry
The findings could pave the way for flexible, sustainable and biocompatible energy-harvesting materials for applications including wearable electronics, implantable medical sensors, electronic skin and biosensors
Rectify presented the discovery and characterization of RTY-406 during the Division of Medicinal Chemistry’s First Time Disclosures session
Nearly all patients — 97.4% — achieved a Valsalva LVOT gradient of 30 mm Hg or less
Engineered tRNA restores full-length protein production in cystic fibrosis models, opening the door to a potential new class of RNA therapeutics
Aims to bring molecular-level Isotope analysis to more labs
Researchers found that sustained use was associated with fewer hospital admissions and emergency department visits and lower monthly healthcare costs, excluding the cost of Zepbound itsel
A key focus of the Palm Conversations International India 2026 conference was the relationship between dietary fat consumption and cardiovascular health
The pharmaceutical polymer-based hydrogel for 3D printing using extrusion-based method has the potential to be used for skin tissue engineering and customised drug delivery
AbbVie is also advancing telisotuzumab adizutecan (Temab-A), an investigational c-Met-directed ADC carrying a topoisomerase 1 inhibitor (Top1i) payload
Bristol Myers Squibb will use Chai’s AI models and molecular-design platform to identify antibody candidates across its portfolio
The researchers identified the Lgr4 gene as particularly responsive to EMF after performing single-cell RNA sequencing of mouse brain tissue exposed to an electromagnetic field of 2.0 millitesla at 60 hertz
The patent further strengthens company’s growing intellectual property portfolio in oncology and reflects the company’s efforts to expand its research and development capabilities beyond its traditional business areas
Second edition of the nationwide outreach programme opens ICMR labs to Classes 9-12 students, launches official website and announces a school competition
Partnership aims to accelerate translation of cutting-edge research into solutions for human health and agriculture, strengthening India’s life sciences innovation ecosystem
The companies have established a new co-innovation hub in London
Mediar will lead research and use its antibody-discovery capabilities and fibrosis-focused biology platform to identify potential drug candidates
Subscribe To Our Newsletter & Stay Updated